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Global glomerular sclerosis and glomerular arteriolar hyalinosis in
insulin dependent diabetes. We studied the lesions of global glomerular
sclerosis and arteriolar hyalinosis in 43 (29 females) insulin-dependent
diabetes mellitus (IDDM) patients whose creatinine clearance (C) was
45 mllmin/l .73 m2 and whose renal biopsies had at least 20 glomeruli
available for stud. These patients, ages 17 to 55 years, had IDDM for
7 to 32 (20 6, X SD) years, C. ranged from 47 to 139 (91 25)
ml/min/l.73 m2 and urinary albumin excretion (UAE) from 5 to 3386
(median = 127) mg124 hrs. Eighteen patients were hypertensive. Thus,
these patients represented a broad clinical range from normal renal
function through overt diabetic nephropathy. The percent of glomeruli
which were globally sclerosed was strongly correlated with Ccr (r =
—0.64, P < 0.0001) and log UAE (r = +0.67, P < 0.001). Hypertension
was more common in patients with more than 10% sclerosed glomeruli
(chi square = 9.5, P < 0.002). Percent sclerosed glomeruli was highly
significantly correlated with the index of severity of the arteriolar
hyalinosis lesion (r = +0.66,P < 0.0001) and mesangial volume fraction(r = +0.61, P < 0.0001). We hypothesize that arteriolar hyalinosis
could contribute to global glomerular sclerosis through severe compro-
mise of glomerular blood flow. Alternately, global glomerular sclerosis
may result from marked mesangial expansion and capillary occlusion.
However, in this broad range of patients it appeared that global
glomerular sclerosis and mesangial expansion were not infrequently
independent diabetic renal lesions which could contribute separately to
the ultimate development of overt diabetic nephropathy.
Research into the pathogenesis of diabetic nephropathy has
increased in the recent past in parallel with the recognition that
diabetes is the major cause of end-stage renal disease in the
Western world [1, 2]. Recent studies have helped to elucidate
the pivotal role of expansion of the glomerular mesangium in
the development of overt diabetic nephropathy [3, 41. This
expansion, primarily of matrix, but also of cells [3, 4], appears
to become clinically important only when it occurs out of
proportion to overall increase in glomerular size, most likely
through a negative impact on glomerular filtration surface [3, 4].
This is suggested by data showing a strong inverse relationship
between measures of mesangial expansion and glomerular
peripheral capillary surface density, on the one hand, and a
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direct relationship between filtration surface and glomerular
filtration rate (GFR), proteinuria and hypertension, on the other
[3, 4]. The pathogenesis and role of glomerular sclerosis (scar-
ring) and its relationship to the other histologic and functional
parameters of diabetic nephropathy have received some atten-
tion in the past [3, 5, 6] but need further clarification. Our earlier
studies suggested that the percentage of glomeruli which un-
dergo global glomerular sclerosis may be increased relatively
early in the evolution of diabetic renal pathology [3]. Results of
the current study of renal biopsies of type I insulin-dependent
diabetic (IDDM) patients with glomerular filtration rates (GFR)
of 45 mI/mm/i .73 m2 or more led us to hypothesize that global
glomerular sclerosis is related to arteriolar hyalinosis.
Methods
Patients
The subjects were drawn from a group of patients evaluated
at the University of Minnesota Hospital as possible candidates
for pancreas transplantation. Forty-three patients were selected
from a larger group of approximately 100 patients with IDDM
based on the following criteria: Creatinine clearance (C) equal
to or greater than 45 mllmin/l .73 m and serum creatinine less
than 2 mg/dl and the availability of at least 20 glomeruli per
biopsy suitable for evaluation by light microscopy. No patients
meeting these criteria were excluded regardless of whether
pancreas transplantation was subsequently performed or not. It
is likely that the incidence of complications was higher in these
patients than in the general IDDM population since the devel-
opment of one or more complications was a frequent motivation
for patients to come for evaluation. Although these patients
may not be entirely representative of IDDM patients, nonethe-
less the interrelationship of a given renal structural change with
other structural changes or with measures of renal function
would remain valid. Further, as is detailed in Results and Tables
1 and 2, this study did include many patients with little or no
renal structural and functional abnormalities. These studies
were approved by the Committee on Use of Human Subjects in
Research at the University of Minnesota. In addition, we
studied renal biopsy tissue obtained at the time of transplant
surgery from 24 normal individuals who served as kidney
donors.
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Renal function studies
Ccr was determined by standard laboratory procedures as
previously described [31. At least two and usually three clear-
ance studies were performed on each patient before renal
biopsy, and the mean of these clearances, where necessary
corrected up to 1.73 m2, were calculated. The normal values for
our laboratory are 95 to 115 ml/min/l.73 m2. Urinary albumin
excretion (UAE) rates were measured by nephelometry using
the Beckman kit (Beckman Instruments, Inc., Fullerton, Cali-
fornia, USA) [7]. The upper limit of normal for UAE for our
laboratory is 22 mg124 hr. Values above 250 mg/24 hr are
regularly associated with Albustix® positivity and are thus
considered as clinical proteinuria. Blood pressure data were
based on repeated determinations available over at least several
days of this admission. Criteria of the Joint National Committee
on the Detection, Evaluation and Treatment of High Blood
Pressure [81 were used in defining hypertension. Since several
patients classified as hypertensive were receiving antihyperten-
sive drugs, only the presence or absence of hypertension, and
not the actual blood pressure was considered. Patients were
defined as having clinically apparent diabetic nephropathy if
two or more of the following features were present: (Car <90
ml/min/l.73 m2, UAE >250 mg/24 hr, hypertension).
Demographic and clinical data
There were 29 IDDM females and 14 IDDM males in this
study (Table 1) and their ages ranged from 17 toSS years (31
7 years, SD). The duration of IDDM at the time of study
varied from 7 to 32 years (Table 1). Cr ranged from 47 to 139
mllmin/l.73 m2 (91 25 ml/min/l.73 m2). UAE ranged from 5 to
3386 mg/24 hrs. Since the urinary albumin excretion values
were not normally distributed, the raw data were log-trans-
formed for statistical comparisons and thus a mean and stan-
dard deviation are not provided (Table 1). Eighteen of the 43
patients were found to have significant hypertension. Twenty-
three of 43 had clinically apparent diabetic nephropathy. We
used renal biopsies from age-matched normal kidney transplant
donors in order to develop normal values for percent glomerular
sclerosis. These 24 normal individuals included 11 females and
their ages ranged from 17 to 55 years (32 10).
Histologic methods
The patients had a percutaneous renal biopsy done as part of
the baseline evaluation of renal disease prior to pancreas
transplantation. Preparation of tissue for grading and measure-
ment of morphologic parameters by light and electron micros-
copy were performed as previously described in detail [3, 4].
Light microscopy: 1.) Percent sclerosed glomeruli. This
parameter was determined on paraffin embedded tissues using
periodic acid-Schiff (PAS) stained sections two apart. Only
biopsies with at least 20 glomeruli were examined. Glomeruli
were considered to have global sclerosis if all of the glomerular
tufts were, at the one extreme, totally replaced by dense scar
or, at the other extreme, were collapsed and involuted as
evidenced by wrinkling of the glomerular basement membrane
(GBM) and marked irregularity of the capillary lumenal space.
At both extremes other features were usually concurrent,
including fibrous crescents, periglomerular fibrosis and associ-
ated tubular atrophy and splitting or reduplication of associated
tubular basement membranes. The concordance between the
two observers in the designation of glomeruli as sclerotic was
almost perfect. It should be noted that lesions of focal segmen-
tal glomerular sclerosis were too uncommon for meaningful
statistical analysis and will not be considered further.
All open and sclerosed glomerular profiles were counted in
PAS sections at least 100 microns apart, so spaced as to
maximize the population of glomeruli for study while minimiz-
ing recounting the same glomeruli. The number of scierosed
glomeruli was then expressed as a percent of the total. Since
sclerosed glomeruli are usually smaller than open glomeruli, a
systematic underestimation of their relative number was antic-
ipated. For this reason, we derived the mean volume [9] of the
open and sclerosed glomeruli (where present) in each biopsy
and corrected the percent sclerosed glomeruli for this size
discrepancy as using a previously published formula [101. Since
this correction did not influence the statistical interrelationships
of percent glomerular sclerosis with other renal structural or
with renal functional parameters, only the uncorrected values
are presented in Results.
2.) Index of arteriolar hyalinosis. Vessels seen on renal
biopsy and available for evaluation included small arteries and
arterioles (afferent and efferent). The pathologic changes in-
volving these vessels, in general, were of two main types:
arteriolar hyalinosis [3. 11, 12] affecting the smaller arterioles,
and atherosclerosis affecting the larger arteries [13].
A semiquantitative estimate [3] of replacement of arteriolar
smooth muscle by waxy, homogeneous PAS-positive material
was determined as the index of arteriolar hyalinosis as follows:
Grade 0.5—incomplete replacement of a few of the vessel
profiles
Grade 1 .0—incomplete replacement of approximately half
the vessel profiles
Grade 1.5—incomplete replacement of most vessel profiles
Grade 2.0—complete replacement of a few vessel profiles
Grade 2.5—complete replacement of approximately half the
vessel profiles
Grade 3.0-complete replacement of most vessel profiles
Grade 3.5—complete replacement of all vessel profiles
Since many biopsies did not have larger vessels for the
evaluation of atherosclerosis, no scoring of these pathologic
changes was undertaken.
Electron microscopy (EM)
Tissues were prepared and photographed for EM morphom-
etry as previously described in detail [3, 4]. Sclerotic glomeruli
were not studied. GBM thickness was obtained by the orthog-
onal intercept method of Jensen, Gunderson and Østerby [14].
The volume fraction of the mesangium (Vv mesangium) and the
surface density of the peripheral capillary wall (SvPGBM) were
estimated by standard stereologic techniques at x 18,000 as
previously detailed [3, 4, 15]. Total mesangial volume in these
open glomeruli was derived from the product of Vv mesangium
and glomerular volume while total filtration surface in these
open glomeruli was derived from the product of SvPGBM and
glomerular volume [3, 4].
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Statistical methods
Relationships between structural and functional parameters
were examined by regression analyses (method of least squares)
and chi-square calculations. In addition, where appropriate,
multiple regression analyses were performed. Since the number
of glomeruli in each biopsy sample (at least 20 per biopsy) could
influence the accuracy (inherent in sampling) of the estimate of
percent sclerotic glomeruli, this value was treated by arcsine
transformation [161. Treating the data in this way did not change
any of the statistical interrelationships of this parameter to
other structural or to functional variables. Thus, only the
untransformed data are presented in the Results. These untrans-
formed values for percent sclerotic glomeruli were weighted for
number of glomeruli per biopsy when related to other structural
or functional variables. Because numerous regression analyses
were performed, only values for 2P of 0.005 were considered
significant. Values for 2P of <0.01 and >0.005 were considered
of borderline significance.
Table 1. Demographic and clinical data
Diabetes Creatinine High"
Case Age Sex duration clearance UAE blood
number years MIF years cc/min/I.73 m2 mg/24 hr pressure
1 26 F 22 99 7 n
2 27 M 18 65 982 y
3 32 F 23 120 12 n
4 34 M 21 106 1852 y
5 34 F 14 103 7 n
6 48 M 27 139 12 n
7 31 F 19 63 1509 y
8 26 F 16 47 3386 y
9 30 M 23 136 252 n
10 24 F 14 131 24 n
11 25 F 21 67 528 y
12 35 F 26 116 9 n
13 30 F 21 50 1353 y
14 29 F 18 93 55 n
15 24 F 23 58 ** y
16 28 F 14 78 10 n
17 30 M 20 80 691 y
18 41 M 23 117 12 n
19 30 F 13 77 578 y
20 38 F 22 78 1276 n
21 36 F 25 71 2247 y
22 41 M 21 118 14 n
23 33 M 19 110 10 n
24 23 F 10 113 224 n
25 28 F 21 84 195 n
26 17 F 15 63 307 y
27 55 F 32 112 6 n
28 37 F 21 86 73 y
29 39 F 25 120 5 n
30 26 M 24 75 304 n
31 35 F 30 87 12 n
32 31 F 17 114 8 n
33 27 M 12 78 2149 y
34 26 F 7 109 7 n
35 31 M 20 124 7 n
36 32 F 20 86 391 n
37 33 M 30 71 968 n
38 23 F 11 96 808 n
39 33 F 17 82 127 y
40 23 M 20 84 347 y
41 42 F 26 64 110 y
42 32 M 30 72 1325 y




7—32 47—139 5—3386 Y = 18
N=25
Median 31 21 86 127
Mean 31 20 91
SD 7 6 25
a UAE = urinary albumin excretion; Nb datum not available
= no; Y = yes
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Table 2. Histologic data










mesangium (X 106 .un3) SvPGBM (x 106 2)
width
nm
I 4 0.0 1.26 0.25 0.32 0.07 0.09 533
2 55 2.5 2.37 0.47 1.11 0.06 0.14 532
3 8 0.3 1.75 0.36 0.63 0.07 0.12 563
4 19 0.0 2.11 0.57 1.20 0.05 0.11 726
5 3 0.0 1.41 0.13 0.18 0.11 0.16 397
6 11 1.5 1.25 0.14 0.18 0.14 0.17 441
7 15 2.3 1.96 0.42 0.82 0.06 0.11 790
8 44 2.5 1.17 0.34 0.40 0.07 0.09 827
9 10 1.5 1.66 0.19 0.32 0.17 0.28 693
10 0 0.5 1.66 0.17 0,28 0.11 0.18 651
11 24 2.5 1.17 0.38 0.44 0.04 0.05 968
12 7 0.3 1.51 0.30 0.45 0.11 0.16 516
13 14 2.5 2.31 0.42 0.97 0.06 0.15 608
14 11 2.5 1.22 0.27 0.33 0.07 0.09 728
15 45 1.8 1.55 0.30 0.47 0.09 0.15 637
16 8 0.1 1.16 0.33 0.38 0.04 0.05 908
17 17 1.3 1.36 0.41 0.56 0.07 0.10 841
18 0 0.8 1.71 0.25 0.43 0.12 0.2! 467
19 8 1,5 1.55 0.52 0.81 0.05 0.08 825
20 42 2.8 2.15 0.44 0.95 0.06 0.13 605
21 50 3.0 3.51 __a — — — —
22 4 0.8 1.88 0.29 0.55 0.08 0.15 631
23 2 0,3 1.44 0.26 0.37 0.12 0.17 544
24 2 0.3 1.43 0.l5 0.21 0.11 0.16 695
25 15 1.5 1.17 0.27 0.32 0.09 0.10 478
26 9 1.5 1.04 0.22 0.23 0.06 0.06 667
27 0 0.1 1.07 0.32 0.34 0.13 0.14 404
28 19 3.0 1.11 0.32 0.36 0.09 0.10 489
29 12 1.8 0.95 0.23 0.22 0.12 0.11 492
30 25 2.3 1.60 0.40 0.64 0.07 0.11 732
31 7 1.5 1.11 — — — — —
32 0 1.5 1.24 0.18 0.22 0.11 0.13 591
33 9 0.5 0.85 0.28 0.24 0.10 0.08 650
34 0 0.0 1.47 0.17 0.25 0.10 0.15 368
35 0 0.5 1.31 0.31 0.41 0.07 0,09 514
36 41 0.8 1.78 0.62 1.10 0.04 0.06 652
37 15 2.5 1.60 0.29 0.46 0.08 0.12 663
38 6 1.0 1.14 — — — — —
39 7 1.0 1.50 0.27 0.41 0.07 0.11 654
40 27 2.0 1.39 0.33 0.46 0.08 0.11 816
41 22 2.5 1.91 — — — — —
42 34 3.5 1.55 0.45 0.7 0.04 0.06 1015
43 35 2.5 1.29 0,47 0.61 0.08 0.! 638
Range 0—55 0—3.5 0.85—3.51 0.13—0.62 0.17—1.2 0.04—0.17 0.05—0.28 368—1015
Median 11 1.5 1.44 0.3 0.41 0.08 0.11 638
Mean 16 1.4 1.5 0.32 0.50 0.08 0.12 634
SD 15 1.0 0.5 0.12 0.28 0.03 0.05 155
C.V. 94 71.0 31.0 36.9 55.8 36.4 38.0 24.4
Abbreviations are: Vv, volume fraction; SvPGBM, surface density of peripheral glomerular basement membrane; GBM, glomerular basement
membrane.
a Datum not available
Results 9.9%, then % glomerular sclerosis <10 and >10 were utilized
for certain analyses.
Histologic data Arteriolar hyalinosis. The most prominent lesion noted in the
Glomerular sclerosis. An average of 40 glomerular profiles small afferent and efferent glomerular arteriolar vessels was the
was counted in each IDDM patient (range 21 to 99). Zero to 55% accumulation of intense staining PAS-positive material with an
(16 15%) of the glomerular profiles in the plane of the sections opaque ground-glass hyaline appearance. This process seemed
examined were globally sclerosed (Table 2). An average of 30 to originate in localized subendothelial areas and then extended
glomerular profiles was counted in each normal person (range into the region of the smooth muscle but, with progression,
20 to 45). Zero to 14(2.1 3.9%) were globally scierosed. Since eventually involved virtually the entire thickness and circum-
the 95th percentile for glomerular sclerosis in the normals was ference of the vessel walls. Sometimes this resulted in occlusive
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Global glomerular sclerosis
%
Fig. 1. Relationship of creatinine clearance and global glomerular
sclerosis (r = +0.64, P < 0.0005).
0 10 20 30 40 50 60
Global glomerular sclerosis
%
Fig. 2. Relationship of urinary albumin excretion and global glomeru-
lar sclerosis. Note triple log scale for urinary albumin excretion (r =
+0.67, P < 0.0005).
encroachment on and, in the extreme, obliteration of the
arteriolar lumen. This hyalinosis process could extend length-
wise along the vessel walls to the arcuate artery. It was our
impression that there was a tendency for clustering of scierosed
glomeruli at the corticomedullary junction, but this could not be
systematically examined since some biopsies did not include
this region of the kidney.
The semiquantitative index of arteriolar hyalinosis ranged
from 0 to 3.5 (1.4 1.0, Table 2).
Structural-functional interrelationships: 1.) Glomerular scle-
rosis and clinical diabetic nephropathy. There was no signifi-
cant interaction between the percent sclerosed glomeruli and
sex (chi square). There was no significant correlation between
age (r = +0.15) or duration of diabetes at time of biopsy (r
+0.22) and percent sclerosed glomeruli. However, none of the
9 patients who had had diabetes for less than 15 years had more
than 10% scierosed glomeruli, while 22 of 34 patients with
duration of more than 15 years had more than 10% sclerosed
glomeruli (chi square = 9.5, P < 0.005). There were significant
correlations between percent glomerular sclerosis and parame-
ters of clinical nephropathy, including Ce,. (r =
—0.64, P <








Normal blood pressure 19 9
Hypertension 2 13
Index of arteriolar hyalinosis
3
Fig. 3. Relationship of global glomerular sclerosis and index of arte-
riolar hyalinosis (r +0.66, P <0.0005).
0.0001, Fig. 1) and log UAE (r = +0.67, P < 0.0001, Fig. 2).
The latter relationship is not immediately visually apparent in
Figure 2 because UAE is plotted on a log scale. Also, hyper-
tension was more common in patients with more than 10%
scierosed glomeruli (chi square = 9.5, P < 0.002, Table 3).
2.) Glomerular sclerosis and arteriolar hyalinosis. There was
a significant correlation between the percent sclerosed glomer-
uli and the IAH (r = +0.66, P < 0.0001, Fig. 3). In fact, there
were no patients with IAH 2 (that is, at least some vessels
having smooth muscle totally replaced by hyaline material) that
did not have  10% scierosed glomeruli (chi square = 17, P <
0.0005; Fig. 3).
3.) Glomerular sclerosis and other structural parameters of
diabetic glomerulopathy. Total mesangial volume per glomeru-
lus (r = +0.6, P < 0.0001), fractional mesangial volume (r =
+0.61, P < 0.000 1) and mean glomerular volume of unocciuded
glomeruli (r +0.53, P < 0.0001) were correlated with the
percent sclerosed glomeruli. There was no correlation between
the percent sclerosed glomeruli and filtration surface per gb-
merulus.
4.) Arteriolar hyalinosis and clinical diabetic nephropathy.
There were significant correlations between the IAH and both
Ccr (r = —0.61, P <0.0001) and log UAE (r +0.57, P <
0.0005). Multiple regression analyses showed that % glomerular
sclerosis and IAH together did not improve the precision of the
correlations with these functional measures compared to each
of these structural variables alone. There was a strong interac-
tion between the more advanced grades of arteriolar hyalinosis
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Chi square = 18.9, P < 0.0005
motensive patients with IAH >2 and seven hypertensive pa-
tients with less severe IAH grades (Table 4). There was no
linear correlation between the duration of diabetes or the age of
the patients and IAH and no influence of the gender of the
patients and IAH.
5.) Arteriolar hyalinosis and other structural measures of
diabetic glomerulopathy. There was no correlation between
IAH and total mesangial volume per glomerulus, Vv mesan-
gium or glomerular volume. Also, there was no correlation
between IAH and SvPGBM, filtration surface per glomerulus or
GBM width. However, as noted above, both Vv mesangium
and IAH were directly correlated with % glomerular sclerosis.
These relationships are illustrated in Figure 4. As can be seen,
most individuals with >10% glomerular sclerosis have IAH
2.0 and Vv mesangium However, two patients had
marked mesangial expansion and increased % glomerular scle-
rosis with minimal or no arteriolar hyalinosis. In contrast, five
patients had increased % glomerular sclerosis with IAH 2.0
but Vv mesangium <0.37. Figure 4 also illustrates that individ-
ual patients reach the stage of clinical diabetic nephropathy
with different combinations and different levels of severity of
the various lesions depicted.
Comparisons of clinical groups. Fourteen patients had UAE
<45 mg124 hr (that is, less than the range generally considered
predictive of the later development of overt nephropathy
(Group 1) and all had normal blood pressures and Cc. Eighteen
patients had UAE >250 mg/24 hr and either reduced Ce,.,
hypertension or both (Group 2). Only two patients (Case
numbers 14 and 24) had isolated microalbuminuria (UAE 45 to
Table 5.
Group 2(N = 18)
Group 1 UAE >250 mg/24 hr(N = 14) decreased Car,
UAE <45 mg124 hr increased BP,
Normal BP and Ccr or both P
Ccr
mllmin!1.73 m2
117 10 72 14 <0.0001
UAE 10 5 1147 841 <0.0001
mg/24 hr
% Sclerosed 3.6 4.3 26.8 14.9 <0.0001
glomeruli
IAH 0.6 0.6 2.0 0.9 <0.0001
Vv mesangium 0.24 0.07 0.41 0.10 <0.0001
Glomerular 1.42 0.3 1.7 0.6 NS
volume
x106 jun3
GBM width 508 86 739 132 <0.0001
nm
SvPGBM 0.10 0.02 0.06 0.02 <0.0001
Filtration surface! 0.15 0.03 0.10 0.03 <0.0001
glomerulus
><jj6
250 mg124 hr). Three (Case numbers 21, 18, and 20, Table 1) had
microalbuminuria and C1 <90 cc/min/1.73 m2. Two cases
(numbers 9 and 14) had isolated reductions in Car, only one of
which had complete histologic studies. These last three sub-
groups were thus considered too small for further analysis.
Preselection dictated that the Group 2 patients had reduced
Ccr and increased UAE compared to the Group 1 patients
(Table 5). Group 2 patients had mean values for Ccr which were
below the range of normal and for UAE which exceeded 1000
mg/24 hr. The % glomerular sclerosis and IAH were much
greater in Group 2 compared to Group 1 patients. Glomerular
volume tended to be larger in the Group 2 compared to the
Group 1 patients, but this did not reach statistical significance.
Vv mesangium and GBM width were increased and SvPGBM
and filtration surface/glomerulus were decreased in Group 2
versus Group 1 patients (Table 5).
Discussion
There has been an evolution of understanding of the term
diabetic glomerulosclerosis." Initially "intercapillary glomer-
ulosclerosis" as used by Kimmelstiel and Wilson [17] referred
specifically to the nodular form of mesangial expansion. Since
then "diabetic glomeruloscierosis" has gradually been more
loosely applied and is now often used to include all the
glomerular lesions produced by diabetes mellitus, including
diffuse and nodular mesangial expansion, GBM thickening,
capillary microaneurysms, arteriolar hyalinosis, hyalin "exuda-
tive" glomerular capillary lesions, and capsular drops [12, 18,
19].
It is known that these complex glomerular changes of diabe-
tes do not develop in parallel. Thus, diffuse mesangial expan-
sion and GBM thickening may not develop at the same rate in
a given patient [31. Further, most patients developing clinical
renal disease from diabetic glomerulopathy either do not de-
velop nodular mesangial expansion or have occasional nodular
lesions on a background usually dominated by diffuse mesangial









Fig. 4. interrelationships of global glomerular sclerosis (the height of
the bars), volume fraction of mesangiu,n (Vv Mes) along the abscissa
and index of arteriolar hyalinosis along the ordinate. Patients with
overt diabetic nephropathy (UAE >250 mg!24 hrs) are depicted by the
bars with hatched lines while patients with UAE 250 mg!24 hrs are
depicted by the grey bars.
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sion as related to the development of clinical diabetic nephrop-
athy was first suggested by Geilman et a! [20]. This was
confirmed by electron microscopic morphometric studies indi-
cating that marked increase in Vv mesangium in IDDM patients
was closely related to the development of clinical diabetic
nephropathy [3]. Further studies suggested that mesangial
expansion may result in reduced GFR through a close inverse
relationship with glomerular filtration surface per glomerulus, a
structural parameter dependent on several variables including
glomerular volume [4, 101. Thus, mesangial expansion appears
to result in compromise of contiguous glomerular capillary
architecture, restriction of filtration surface. This is ultimately
associated with reduction in GFR and with the development of
hypertension and proteinuria [3, 4J. At the end of this process
massive mesangial expansion can lead to capillary closure [21]
and to the appearance of large sclerotic glomeruli [181.
However, our examination of structural-functional relation-
ships in diabetic nephropathy suggested that some patients had
increased numbers of globally scierosed glomeruli at an earlier
stage of disease, prior to the development of marked mesangial
expansion. Thus, this study was undertaken to better under-
stand the genesis of glomerular scarring in this disorder.
The patients studied here represented a broad demographic,
pathologic and clinical range of renal disease in IDDM. How-
ever, patients with C. of less than 45 ml/min/173 m2 were
excluded in order to avoid studying the end-stage kidney. We
did not find an increased percentage of sclerotic glomeruli in the
first 15 years of diabetes. Similarly, an index of arteriolar
hyalinosis of two or more, indicating at least some arteriolar
walls virtually totally replaced by hyaline material, was also
uncommon in the first 15 years of IDDM, a finding consistent
with the classic observation of E.T. Bell on this subject [12].
The most precise structural correlate of percent glomerular
sclerosis was the severity of the arteriolar hyalinosis lesion.
Measures of mesangial expansion were also significantly cone-
lated with percent glomerular sclerosis, albeit less precisely.
Our results indicate that a broad spectrum of patients ranging
from those with minimal lesions to those with well established
clinical nephropathy are necessary for the relationships de-
scribed herein to become apparent. Clearly, from such correl-
ative studies it is impossible to conclude whether arteriolar
hyalinosis or mesangial expansion or both are causally linked to
glomerular sclerosis. Nonetheless, the results of the current
studies and those of others [5, 18, 221 are consistent with both
vascular and mesangial changes contributing to sclerosis of
glomeruli in IDDM.
Since percent of glomeruli with global sclerosis and measures
of mesangial expansion were correlated with one another and
both are related to renal function in IDDM patients [3], it is not
possible, from the present study, to separately estimate the
potential functional impact of the arteriolar and the global
glomerular sclerosis lesions described here. Earlier studies
indicating remarkably precise relationships between GFR and
filtration surface of nonsclerosed glomeruli [4, 10] support the
primacy of the mesangial expansion process in the genesis of
clinical diabetic nephropathy. Nonetheless, there was a subset
of patients in the present study with overt diabetic nephropathy
with only moderate mesangial expansion but with advanced
arteriolar hyalinosis lesions and increased percent sclerosed
glomeruli. Two patients had overt diabetic nephropathy with
marked mesangial expansion and increased percent scierosed
glomeruli with little or no arteriolar changes. Such patients
illustrate the diversity of the renal pathology of diabetes which
is associated with clinical renal disease.
The pathogenesis of the arteriolar hyalinosis lesions of dia-
betes is not well understood. The immunohistochemical char-
acteristics of this lesion include the deposition of albumin,
immunoglobulins, fibrin and complement and suggest a local
accumulation of plasma proteins in the vessel wall [23—25].
These findings parallel those of the exudative lesions of the
glomerular capillary subendothelial space and the capsular drop
[26]. These lesions may be biologically active as indicated by
their ability to fix heterologous complement [23]. Whether this
deposition occurs as a consequence of altered vascular perme-
ability to plasma proteins per se, as leakage consequent to
hemodynamic perturbations, or as failure to clear leaked pro-
teins is not known. A full discussion of the possible pathogenic
mechanisms involved in the arteriolar hyalinosis lesions is
beyond the scope of this paper. Nonetheless, since our studies
indicate that the early lesions of vascular hyalinosis frequently
precede the development of systemic hypertension and ad-
vanced lesions may be present in normotensive patients, it is
possible to conclude that systemic hypertension is not a neces-
sary precondition for their development.
In summary, this paper contends that the lesion of global
glomerular sclerosis is an important component of diabetic
nephropathy. A link between glomerular sclerosis and glomer-
ular arteriolar hyalinosis is also suggested. Clearer understand-
ing of these processes is likely to advance our knowledge of
important factors propelling the diabetic patient towards kidney
failure.
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